FDA Inspection 639703 — Janssen Pharmaceutica, N.V.

Janssen Pharmaceutica, N.V. — FEI 3002807336

The FDA completed an inspection of Janssen Pharmaceutica, N.V. on December 18, 2009 in Beerse. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 18, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Beerse (Belgium)